Eli Lilly's experimental weight loss drug shed 21% of body weight in diabetes trial
- Eli Lilly: 13 events in the last 90 days
- Previous: 5 days earlier · Novo is betting on its next chapter as Eli Lilly gains more ground in GLP-1s
What happened
Participants with a higher starting BMI lost up to 23% of body weight, the most ever recorded in a drug trial for diabetes patients
Summary assembled by rule from the sources below